Menu Philippe 4
4 · SOPHiA GENETICS SA · Filed Apr 21, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) CMO Philippe Menu Sells 608 Shares
What Happened
- Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA, sold 608 shares in an open-market transaction on April 20, 2026. The filing reports a weighted average price of $5.20 per share for total proceeds of approximately $3,162. The sale was made to satisfy tax withholding obligations arising from restricted stock units that vested on April 18, 2026.
Key Details
- Transaction date: 2026-04-20; Form 4 filed: 2026-04-21 (within the 2-business-day reporting window).
- Price: weighted average $5.20; trades ranged between $5.10 and $5.29 (per footnote).
- Shares sold: 608; total proceeds ≈ $3,162.
- Post-transaction holdings: not specified in the provided filing excerpt.
- Footnotes: Sale was effected under a pre-established Rule 10b5-1(c) trading plan and was non-discretionary, executed to cover tax withholding on RSU vesting. The filer can provide a breakdown of shares sold at each price within the reported range upon written request.
Context
- This was an administrative, tax-withholding sale tied to RSU vesting and executed under a 10b5-1 plan, a routine event that typically does not indicate a change in insider sentiment.
Insider Transaction Report
Form 4
Menu Philippe
Chief Medical Officer
Transactions
- Sale
Ordinary Shares
[F1][F2]2026-04-20$5.20/sh−608$3,162→ 266,388 total
Footnotes (2)
- [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.10 to $5.29, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Elimara Brunetto as Attorney-in-fact for Philippe Menu|2026-04-21